PROCUREMENT-STATE DRUG LABEL Senate SponsorsSen. Laura M. Murphy 1/13/2021SenateSession Sine Die 30 ILCS 500/25-210 newAmends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules. 2/14/2020SenateFiled with Secretary by Sen. Laura M. Murphy 2/14/2020SenateFirst Reading 2/14/2020SenateReferred to Assignments 2/25/2020SenateAssigned to Executive 3/4/2020SenateTo Subcommittee on Procurement 3/18/2020SenateRule 2-10 Committee Deadline Established As April 2, 2020 3/25/2020SenateRule 2-10 Committee Deadline Established As April 24, 2020 3/25/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 7, 2020 4/12/2020SenatePursuant to Senate Rule 3-9(b) / Referred to Assignments 4/16/2020SenateRule 2-10 Committee Deadline Established As April 30, 2020 4/23/2020SenateRule 2-10 Committee Deadline Established As May 7, 2020 4/23/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 15, 2020 4/30/2020SenateRule 2-10 Committee Deadline Established As May 15, 2020 4/30/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 22, 2020 5/7/2020SenateRule 2-10 Committee Deadline Established As May 22, 2020 5/7/2020SenateRule 2-10 Third Reading/Passage Deadline Established As May 29, 2020 5/15/2020SenateRule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020 1/13/2021SenateSession Sine Die